Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4651 AL 4665

Animal Models of Parkinson's Disease

Dawson VL, Dawson TM.

Cold Spring Harb Perspect Med. 2025 Dec 1;15(12):a041644. doi: 10.1101/cshperspect.a041644.

Glycosylation in neuroinflammation: mechanisms, implications, and therapeutic strategies for neurodegenerative diseases

Cheng S, Xiao B, Luo Z.

Transl Neurodegener. 2025 Sep 22;14(1):47. doi: 10.1186/s40035-025-00506-4.

Neurotransmitter Transporters-Unraveling Molecular Mechanisms and Therapeutic Opportunities

Sitte HH, Gether U, Cabrita E, Stockner T.

J Neurochem. 2025 Sep;169(9):e70240. doi: 10.1111/jnc.70240.

Focused Ultrasound versus Radiofrequency Ablation for Pallidothalamic Tractotomy: Looking beyond the Bilateral Effects

Makharia A, Radhakrishnan DM, Kumar Srivastava A.

Mov Disord. 2025 Oct;40(10):2277-2278. doi: 10.1002/mds.70057. Epub 2025 Sep 23.

Reply to: "Focused Ultrasound versus Radiofrequency Ablation for Pallidothalamic Tractotomy: Looking beyond the Bilateral Effects"

Ikezawa J, Yokochi F, Yamaguchi T, Abe K, Kamiyama T, Kawazoe T, Horisawa S, Sasanuma J, Hori T, Hori H, Kakegawa T, Okiyama R, Takahashi K, Taira T.

Mov Disord. 2025 Oct;40(10):2279-2280. doi: 10.1002/mds.70051. Epub 2025 Sep 23.

Imaging microtubule dynamics: A new frontier in biomarker development for neurodegenerative diseases

Damuka N, Lockhart SN, Solingapuram Sai KK.

Alzheimers Dement. 2025 Sep;21(9):e70670. doi: 10.1002/alz.70670.

Behaviorally Informed Interventions to Promote Activity in the Home and Community for Adults With Neurological Disorders: A Systematic Review and Meta-Analysis

LaMarca A, Karim R, Larsen G, Tse I, Wechsler S, Gauthier LV, Keysor J.

Phys Ther. 2025 Nov 3;105(11):pzaf117. doi: 10.1093/ptj/pzaf117.

Comparing Parkinson's Disease Medications Categorised by Location in New South Wales, Australia: Linking the 45 and Up Study and the Pharmaceutical Benefits Scheme (PBS) Data

Logan PA, Micalos PS, Fealy S, Bramble M, Wong A.

Aust J Rural Health. 2025 Oct;33(5):e70094. doi: 10.1111/ajr.70094.

Management of neuropsychiatric, motor and non-motor symptoms in Parkinson´s disease after long distance air travel: a consensus view

Poplawska-Domaszewicz K, Kaasinen V, van der Plas AA, Barbosa PM, Heim B, Slawek J, Falup-Pecurariu C, Pirtosek Z, Storch A, Chen R, Schröter N, Jost WH, Chaudhuri KR.

J Neural Transm (Vienna). 2025 Nov;132(11):1699-1703. doi: 10.1007/s00702-025-02982-4. Epub 2025 Sep 23.

Targeting mGluR7 in Parkinson's disease: a novel approach to neuroprotection and synaptic therapies

Singh G, Aran KR.

Inflammopharmacology. 2025 Oct;33(10):5977-5994. doi: 10.1007/s10787-025-01921-9. Epub 2025 Sep 23.

Pleiotropic regulatory mechanisms and targeted therapeutic prospects of Galectin-3 in aging-related diseases

Yuan J, Dong X, Gao Y, Nao J.

Neurotherapeutics. 2025 Oct;22(6):e00744. doi: 10.1016/j.neurot.2025.e00744. Epub 2025 Sep 22.

Reply to "Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals"

Fan Y, Hu Z, Yan QQ, Wan JJ, Liu J.

Mov Disord. 2025 Nov;40(11):2546-2548. doi: 10.1002/mds.70060. Epub 2025 Sep 24.

Reconsidering the Clinical Foundations of NSD-ISS in PD Staging

Onder H, Uzel T, Bizpinar O.

Mov Disord. 2025 Nov;40(11):2549-2550. doi: 10.1002/mds.70061. Epub 2025 Sep 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias